NBY News and Press, NovaBay Pharmaceuticals Inc. From 03/30/23

Product sales increased 15% for the quarter and 41% for the year, driven by increasingly diversified revenue streams Wound care revenue increased 143% year over year Digital marketing program optimization continued to drive higher product sales on lower marketing spend Eye...

NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY) announces that it will report financial results for the three and 12 months ended December 31, 2022 after market close on Thursday, March 30, 2023 and will hold an investment community conference call that day beginning at 4:30 p.m. ...

NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY) announces a partnership with Eyeganics to sell OTC Organic Tears (0.2% organic glycerin) on Avenova.com and through Avenova’s physician-dispensed channel . Organic Tears has no additives or artificial chemicals an...

2023-03-07 07:31:59 ET NovaBay Pharmaceuticals ( NYSE: NBY ) jumps 10% premarket after announcing the launch of OTC Avenova Eye Health Support oral supplement featuring a combination of MaquiBright, a nutrient-rich, antioxidant-dense extract of the superfruit maqu...

Avenova Eye Health Support expands the Avenova dry eye product line with a differentiated product combining high-quality, concentrated omega-3 oils with the unique nutrient-rich antioxidant maqui berry NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY) announces the laun...

MASHTEUIATSH, Quebec, Feb. 28, 2023 (GLOBE NEWSWIRE) -- NioBay Metals Inc. (“NioBay” or the “Company”) NioBay Metals Inc. and Pekuakamiulnuatsh Takuhikan announce the signing of a cooperation agreement for the advanced exploration and development of the Crevier Project...

MONTRÉAL, Feb. 13, 2023 (GLOBE NEWSWIRE) -- NioBay Metals Inc. (“NioBay” or the “Company”) (TSX-V: NBY) (OTCQB: NBYCF) would like to provide an update on the delay in the delivery of assay results following the drilling program on the “extension” of ...

MONTREAL, Feb. 08, 2023 (GLOBE NEWSWIRE) -- NioBay Metals Inc. (“NioBay” or the “Company”) (TSX-V: NBY) (OTCQB: NBYCF) is proud to announce that Dawn Madahbee Leach, a member of the Company's board of directors, received the 2023 Business Lifetime Achievement Award fro...

Calm Cool + Corrected Eczema + Dermatitis Clinical Repair Balm to be Featured on “It Takes Two with Mary & Sandra” at 2 p.m. ET and “Girl’s Night In With Courtney & Jane” at 9 p.m. ET NovaBay ® Pharmaceuticals, Inc . (NYSE American...

NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY) announces that Justin Hall, CEO, will present a company overview at the virtual Sequire Biotechnology Conference on Thursday, February 2 at 2:30 p.m. Eastern time. To register for the event, visit the Sequire Biotechnology website...